Reference
NICE. NICE says liver cancer treatment to stay within the Cancer Drugs Fund, but not recommended for routine NHS use. Internet Document : 30 Dec 2017. Available from: URL: https://www.nice.org.uk/news/article/nice-says-liver-cancer-treatment-to-stay-within-the-cancer-drugs-fund-but-not-recommended-for-routine-nhs-use
Rights and permissions
About this article
Cite this article
NICE: liver cancer drug to stay in Cancer Drug Fund. PharmacoEcon Outcomes News 769, 37 (2017). https://doi.org/10.1007/s40274-017-3673-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3673-9